BDI RESEARCHER AWARDED ENTERPRISE IRELAND COMMERCIALISATION FUND AWARD
Congratulations to Dr. Vitaly Efremov who received an Enterprise Ireland Commercialisation Fund (CF) award to develop and validate in a clinical setting a novel, optical-based technology for the quantitative determination of fibrinogen concentration in blood. This work will be undertaken in collaboration with Dr. Patrick Thornton (Rotunda Hospital), and will be applied for monitoring complications arising from postpartum haemorrhage (PPH) during pregnancy, which contribute significantly towards causes of maternal morbidity and mortality. The project aims to develop a next-generation, fully-integrated 'point-of-care' fibrinogen testing device that is compatible with deployment within the emergency room or operating theatre. This will include the development of novel microfluidic solutions, design of miniaturised optics and development of companion software for robust data extraction and analysis.